A case of facial redness in atopic dermatitis occurring during dupilumab treatment successfully treated with topical delgocitinib ointment
- 18 February 2021
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (2), e14888
- https://doi.org/10.1111/dth.14888
Abstract
Click on the article title to read more.Keywords
This publication has 8 references indexed in Scilit:
- Dupilumab-resistant facial erythema - Dermoscopic, histological and clinical findings of three patientsAllergology International, 2021
- Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case SeriesAllergy, Asthma & Immunology Research, 2020
- Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World PracticeJournal of Clinical Medicine, 2020
- Emerging Topical and Systemic JAK Inhibitors in DermatologyFrontiers in Immunology, 2019
- Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case seriesBritish Journal of Dermatology, 2019
- Dupilumab facial redness: Positive effect of itraconazoleJAAD Case Reports, 2019
- Characterizing dupilumab facial redness: A multi-institution retrospective medical record reviewJournal of the American Academy of Dermatology, 2019
- The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapyJAAD Case Reports, 2018